Author:
Egan Caitlin,Greenberg Jacques,Fahey Thomas J.
Publisher
Springer International Publishing
Reference148 articles.
1. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115.
2. Sica DA. Endocrine causes of secondary hypertension. J Clin Hypertens (Greenwich). 2008;10(7):534–40.
3. Young WF Jr, Calhoun DA, Lenders JWM, Stowasser M, Textor SC. Screening for endocrine hypertension: an endocrine society scientific statement. Endocr Rev. 2017;38(2):103–22.
4. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 2001;86(11):5210–6.
5. Izzo L, Sympathoadrenal Activity J. Catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage. Am J Hypertens. 1989;2(12_Pt_2):305S–12S.